Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty

Circulation

Volumn 98, Issue 22, 1998, Pages 2377-2382

  Horie, Hajime ^a   Takahashi, Masayuki ^a   Minai, Kazuo ^a   Izumi, Masafumi ^a   Takaoka, Atsushi ^a   Nozawa, Masato ^b   Yokohama, Hiroshi ^a   Fujita, Tamotsu ^a,b   Sakamoto, Taizo ^b   Kito, Osamu ^b   Okamura, Hiroshi ^b   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b Okamura Memorial Hospital   (Japan)

Author keywords

Angioplasty; Myocardial infarction; Prognosis; Reperfusion

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; DISEASE ASSOCIATION; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; Q WAVE; REPERFUSION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0032403032     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.22.2377     Document Type: Article

References (28)

1. Gruppo Italiano per lo Studio della Streptochinasi nell' infarto miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet. 1987;2: 871-874.
2. O'Neill W, Timmis GC, Bourdillon PD, Lai P, Ganghadarhan V, Walton J, Ramos R, Laufer N, Gordon S, Schork MA, Pitt B. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med. 1986;314: 812-818.
3. Sheehan FH, Braunwald E, Canner P, Dodge HT, Gore J, Van Natta P, Passamani ER, Williams DO, Zaret B. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue- type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI) Phase 1 Trial. Circulation. 1987;75:817-829.
4. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction and improved survival: should the paradigm be expanded? Circulation. 1989;79:441-444.
5. LATE Study Group. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet. 1993;342:759-766.
6. Topol EJ, Califf RM, Vandormael M, Grines CL, George BS, Sanz ML, Wall T, O'Brien M, Schwaiger M, Aguirre FV, Young S, Popma JJ, Sigmon KN, Lee KL, Ellis SG, and the Thrombolysis, and Angioplasty in Myocardial Infarction-6 Study Group. A randomized trial of late reperfusion therapy for acute myocardial infarction. Circulation. 1992;85: 2090-2099.
7. Dzavik V, Beanlands DS, Davies RF, Leddy D, Marquis JF, Teo KK, Ruddy TD, Burton JR, Humen DP. Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (< 6 weeks) Q-wave acute myocardial infarction (Total Occlusion post-Myocardial Infarction Intervention study [TOMIIS] - A pilot study). Am J Cardiol. 1994;73:856-861.
8. Sabri MN, DiSciascio G, Cowley MJ, Goudreau E, Warner M, Kohli RS, Bajaj S, Kelly K, Vetrovec G. Immediate and long-term results of delayed recanalization of occluded acute myocardial infarction-related arteries using coronary angioplasty. Am J Cardiol. 1992;69:575-578.
9. Pizzeti G, Belotti G, Margonato A, Cappelletti A, Chierchia SL. Coronary recanalization by elective angioplasty prevents ventricular dilation after anterior myocardial infarction. J Am Coll Cardiol. 1996;28:837-845.
10. Hochman JS. Has the time come to seek and open all occluded infarct-related arteries after myocardial infarction? J Am Coll Cardiol. 1996;28: 846-848.
11. Rentrop PK, Thronton JC, Feit F, Buskirk M. Determinants and protective potential of coronary collaterals as assessed by angioplasty model. Am J Cardiol. 1988;61:677-684.
12. Kennedy JW, Trenholme SE, Kasser IS. Left ventricular volume and mass from single-plane cineangiogram: a comparison of anteroposterior and right anterior oblique methods. Am Heart J. 1970;80:343-352.
13. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J, Woo HW. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation. 1986;74:293-305.
14. Haase J, Di Mario C, Slager CJ, van der Giessen WJ, den Boer A, de Feyter PJ, Reiber JHC, Verdouw PD, Serruys PW. In-vivo validation of on-line and off-line geometric coronary measurements using insertion of stenosis phantoms in porcine coronary arteries. Cathet Cardiovasc Diagn. 1992;27:16-27.
15. Rosalki SB. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med. 1967;69:696-705.
16. Katus HA, Yasuda T, Gold HK, Leinbach RC, Strauss HW, Waksmonski C, Haber E, Khaw BA. Diagnosis of acute myocardial infarction: detection of circulating cardiac myosin light chains. Am J Cordiol. 1984;54:964-969.
17. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685-691.
18. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation. 1995;91:476-485.
19. EMERAS Collaborative Group. Randomized trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet. 1993;342: 767-772.
20. Veen G, Meyer A, Verbeugt FW, Werter CJ, de Swart H, Lie KL, van der Pol JM, Michels HR, van Eenige MJ. Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographie results of the APRICOT study: antithrombolytics in the Prevention of Reocclusion in Coronary Thrombolysis. J Am Coll Cardiol. 1993;22:1755-1762.
21. Kim CB, Braunwald E. Potential benefits of late reperfusion of infarct myocardium: the open artery hypothesis. Circulation. 1993;88: 2426-2436.
22. Zijlstra F, De Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680-684.
23. Isobe M, Nagai R, Ueda S, Tsuchimori H, Nakaoka H, Takaku F, Yamaguchi T, Machii K, Nobuyoshi M, Yazaki Y. Quantitative relationship between left ventricular function and serum cardiac myosin light chain 1 levels in patients with acute myocardial infarction. Circulation. 1987;76:1251-1261.
24. Hirayama A, Adachi T, Asada S, Mishima M, Nanto S, Kusuoka H, Yamamoto K, Matsumura Y, Hori M, Inoue M, Kodama K. Late reperfusion for acute myocardial infarction limits the dilatation of left ventricle without the reduction of infarct size. Circulation. 1993;88:2565-2574.
25. Sabia PJ, Powers ER, Ragosta M, Sarembock IJ, Burwell LR, Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med. 1992;327: 1825-1831.
26. Welty FK, Mittleman MA, Lewis SM, Kowalker WL, Healy RW, Shubrooks SJ, Muller JE. A patent infarct-related artery is associated with reduced long-term mortality after angioplasty for postinfarction ischemia and ejection fraction <50%. Circulation. 1996;93:1496-1501.
27. Stack RS, O'Connor CM, Mark DB, Hinohara T, Phillips HR, Lee MM, Ramirez NM, O'Callaghan WG, Simonton CA, Carlson EB, Morris KG, Behar VS, Kong Y, Peter RH, Califf RM. Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase. Circulation. 1988;77: 151-161.
28. Ohman EM, Califf RM, Topol EJ, Candela R, Abbottsmith C, Ellis S, Sigmon KN, Simonton CA, Kereiakes D, George B, Stack RS. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation. 1990;82:781-791.